Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment

Although gemcitabine monotherapy is the standard treatment for advanced pancreatic cancer, patient outcome varies significantly, and a considerable number do not benefit adequately. We therefore searched for new biomarkers predictive of overall patient survival. Using LC-MS, we compared the base-lin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Matsubara, Junichi, Ono, Masaya, Honda, Kazufumi, Negishi, Ayako, Ueno, Hideki, Okusaka, Takuji, Furuse, Junji, Furuta, Koh, Sugiyama, Emiko, Saito, Yoshiro, Kaniwa, Nahoko, Sawada, Junichi, Shoji, Ayako, Sakuma, Tomohiro, Chiba, Tsutomu, Saijo, Nagahiro, Hirohashi, Setsuo, Yamada, Tesshi
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Biochemistry and Molecular Biology 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860233/
https://ncbi.nlm.nih.gov/pubmed/20061307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M900234-MCP200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados